| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |